Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.
Liberty Biopharma Price Performance
The company has a market cap of C$21.54 million and a P/E ratio of -12.66. The stock has a 50-day simple moving average of C$2.00 and a 200 day simple moving average of C$2.00. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
See Also
- Five stocks we like better than Liberty Biopharma
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Micron Stock Under $100: Seize the AI-Driven Upside
- Comparing and Trading High PE Ratio Stocks
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
